Pfizer And Moderna Reap Rewards Of Expanded US And EU Deals

Hundreds Of Millions More Doses Purchased

The two rival mRNA vaccines are proving attractive in the face of new variants, and could dominate once SARS-CoV2 enters the ‘endemic’ stage.

Pfizer Science Will Win Poster
A person wearing a protective face mask walks past the Pfizer HQ in December in New York City.

The EU has agreed major expansions of its deals with the COVID-19 vaccine makers Pfizer/BioNTech and Moderna, adding a further 350 million vaccine doses to its confirmed orders.

These follow similar moves from the US government, which agreed to buy an extra 100 million doses from both companies...

More from Business

More from Scrip